Crisil assigns ‘A1+’ rating to commercial paper of Sun Pharma

05 Oct 2017 Evaluate

Credit rating agency, Crisil has assigned ‘A1+’ rating to Commercial Paper of Sun Pharmaceutical Industries. The rating agency has also reaffirmed ratings of ‘AAA/Stable’ and ‘A1+’ on the long term and short term bank facilities of the company, respectively.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1729.95 -31.50 (-1.79%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×